These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3392240)

  • 1. Low-dose acebutolol given once daily in the treatment of chronic angina pectoris.
    Piña IL; Smith EV; Weidler DJ
    J Clin Pharmacol; 1988 May; 28(5):427-30. PubMed ID: 3392240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of acebutolol in chronic stable angina using single-blind and randomized double-blind protocol.
    Lee G; DeMaria AN; Favrot L; Hermanovich J; Kozina J; Krieg P; Kimchi A; Laddu A; Mason DT
    J Clin Pharmacol; 1982; 22(8-9):371-8. PubMed ID: 6813360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the beta-blocking drug acebutolol in angina pectoris.
    Rod JL; Admon D; Kimchi A; Gotsman MS; Lewis BS
    Am Heart J; 1979 Nov; 98(5):604-12. PubMed ID: 495406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable effects of acebutolol on exercise performance and angina in men with coronary artery disease.
    Steele P; Gold F
    Chest; 1982 Jul; 82(1):40-3. PubMed ID: 7044708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acebutolol in angina pectoris: objective assessment using graded treadmill testing.
    Kimchi A; Gotsman MS; Lewis BS
    Isr J Med Sci; 1978 Sep; 14(9):941-7. PubMed ID: 363642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute effects of oral acebutolol on exercise tolerance in patients with stable angina pectoris (author's transl)].
    Scrutinio D; De Toma L; Mangini S; Boscia F; Quagliara D; De Nicolò M; Rizzon P
    G Ital Cardiol; 1981; 11(3):364-72. PubMed ID: 7026336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac ischemia on exercise. Effect of nifedipine and acebutolol singly and in combination (author's transl)].
    Strasser R; Klepzig H
    MMW Munch Med Wochenschr; 1981 Aug; 123(35):1303-6. PubMed ID: 6793850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acebutolol on dynamic ischemic ECG changes: a study using ambulatory twenty-four-hour ECG monitoring.
    Admon D; Kamchi A; Lewis BS; Gotsman MS
    Isr J Med Sci; 1979 Mar; 15(3):207-11. PubMed ID: 37190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acebutolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.
    Singh BN; Thoden WR; Wahl J
    Pharmacotherapy; 1986; 6(2):45-63. PubMed ID: 3012486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of acebutolol in chronic stable angina: drug-induced positive antinuclear antibody.
    Bloomquist JN; Laddu A; Engler R
    J Cardiovasc Pharmacol; 1984; 6(5):735-8. PubMed ID: 6209474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
    Pandhi P; Sethi V; Sharma BK; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):598-600. PubMed ID: 3908331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of acebutolol in angina pectoris].
    Rey G; Wazana M; Sacrez A
    Cardiology; 1978; 63 Suppl 1():32-6. PubMed ID: 688290
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of acebutolol on chronic stable angina pectoris. A placebo-controlled, double-blind, randomized crossover study.
    DiBianco R; Singh S; Singh JB; Katz RJ; Bortz R; Gottdiener JS; Spodick DH; Laddu AR; Fletcher RD
    Circulation; 1980 Dec; 62(6):1179-87. PubMed ID: 6777070
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of once and twice daily administration of acebutolol in hypertension.
    Watson RD; Stallard TJ; Littler WA
    Br J Clin Pharmacol; 1980 Feb; 9(2):209-12. PubMed ID: 6766731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
    Singh BN; Thoden WR; Ward A
    Drugs; 1985 Jun; 29(6):531-69. PubMed ID: 3891306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between clinical and exercise responsiveness to beta-blockade in angina.
    Tremblay G; Biron P; Proulx A
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):508-12. PubMed ID: 32144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
    Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
    Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily administration of acebutolol in treatment of hypertension.
    Weber MA; Drayer JI
    Am Heart J; 1985 May; 109(5 Pt 2):1175-8. PubMed ID: 2859782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acebutolol and left ventricular function: assessment by radionuclide angiography.
    Katz RJ; DiBianco R; Singh S; Bortz R; Bates HR; Sauerbrunn B; Laddu AR; Fletcher RD
    Clin Pharmacol Ther; 1981 Feb; 29(2):149-54. PubMed ID: 7460480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.